人類在生理週期中紅血球內穀胱甘肽和過氧化氫酶的表現

女性依自然月經週期分兩組：經期後第10-20天為A組(16人)，是動情激素高峰時期； ... 因此，我們推論紅血球內抗氧化物質穀胱甘肽及過氧化氫酶含量與動情激素表現量有關。

資料載入處理中... 跳到主要內容 臺灣博碩士論文加值系統 ::: 網站導覽| 首頁| 關於本站| 聯絡我們| 國圖首頁| 常見問題| 操作說明 English |FB專頁 |Mobile 免費會員 登入| 註冊 功能切換導覽列 (188.166.176.73)您好！臺灣時間：2022/05/1322:47 字體大小：       ::: 詳目顯示 recordfocus 第1筆/ 共1筆  /1頁 論文基本資料 摘要 外文摘要 目次 參考文獻 QRCode 本論文永久網址: 複製永久網址Twitter研究生:蘇琬玲研究生(外文):Wan-Ling論文名稱:人類在生理週期中紅血球內穀胱甘肽和過氧化氫酶的表現論文名稱(外文):Theexpressionsofhumanglutathioneandcatalaseinerythrocyteduringthemenstrualcycle指導教授:劉哲育指導教授(外文):Jer-YuhLiu學位類別:碩士校院名稱:中山醫學大學系所名稱:生化暨生物科技研究所學門:生命科學學門學類:生物科技學類論文種類:學術論文論文出版年:2008畢業學年度:96語文別:中文論文頁數:50相關次數: 被引用:0點閱:187評分:下載:0書目收藏:0 本實驗主要是研究動情激素與紅血球內抗氧化物質如穀胱甘肽(glutathione;GSH)和過氧化氫酶(catalase)的相關性。

採集總人數為59人，女性43人，男性16人。

女性依自然月經週期分兩組：經期後第10-20天為A組(16人)，是動情激素高峰時期；第0-9天及21-30天為B組(27人)，是動情激素低量期。

A組穀胱甘肽的含量(4.4±2.3μg/mg)較B組(3.2±1.8μg/mg)為顯著高(P＜0.05)。

而且A組過氧化氫酶的活性(210±72IU/mg)也較B組(168±62IU/mg)為顯著高(P＜0.05)。

同時動情激素變化A組(184±106pg/mL)也是較B組(105±56pg/mL)為顯著高(P＜0.01)。

若依動情激素平均值(134pg/mL)為界線分兩組，平均值以上為C組(13人)，平均值以下為D組(29人)。

穀胱甘肽含量C組(4.0±1.6μg/mg)與D組(3.5±2.2μg/mg)無顯著差異。

然而過氧化氫酶的活性C組(217±78IU/mg)較D組(167±60IU/mg)為顯著高(P<0.05)。

另外男性與女性各組並無顯著差異。

因此，我們推論紅血球內抗氧化物質穀胱甘肽及過氧化氫酶含量與動情激素表現量有關。

Thepurposeofthisstudyistoinvestigatethecorrelationbetweenestrogenandantioxidantssuchas(GlutathioneGSH,catalase)intheerythrocytes.Thetotalnumberpopulationofthisstudywasconsistantedof59healthypersons(43femaleand16male).Thefemalegroupwasdividedinto2groupsaccordingmenstrualcycle:groupAconsistedof16female(10-20daysaftermenstrualcycle)isinthestageofhigherestrogenlevel;groupBconsistedof27females（1-9and21-30daysaftermenstrualcycle）isinthelowerestrogenlevel.TheresultsshowedthattheglutathioneGSHlevelingroupA(4.4±2.3μg/mg)wassignificantlyhigherthanthatingroupB(3.2±1.8μg/mg)(P＜0.05).howeverthecatalaselevelingroupA(210±72IU/mg)wasalsosignificantlyhigherthanthatingroupB(168±62IU/mg)(P＜0.05).TheestrogenlevelingroupA(184±106pg/mL)ishigherthanthatingroupB(105±56pg/mL)(P＜0.01).Accordingtotheaverageestrogen134pg/mLthehigherestrogenlevelgroupC(n=13)andlowerestrogenlevelgroupD(n=29).Thesamplesweredividedistotwogroups.ThereisnodifferenceofGlutathionelevelbetweengroupC(4.0±1.6μg/mg)andgroupD(3.5±2.2μg/mg).HoweverthereissignificantdifferenceofcatalaselevelbetweengroupC(217±78IU/mg)andgroupD(167±60IU/mg)(P＜0.05).Nodifferenceofantioxidantswasobservedinbetweenmaleandfemale.Thuswesuggestedthattheexpressionofantioxidants(Glutathioneandcatalase)inerythrocyteiscorrelatedwiththelevelofestrogen. 目錄壹、中文摘要……………………………………………………………3貳、英文摘要…………………………………………………………4參、縮寫表……………………………………………………………．5肆、前言…………………………………………………………………7伍、實驗動機……………………………………………………………16陸、實驗方法與材料……………………………………………………17柒、實驗結果…………………………………………………………23捌、討論………………………………………………………………．26玖、參考文獻……………………………………………………………30拾、圖表…………………………………………………………………43 玖、參考文獻1.AyresS,TangM,SubbiahMT.(1996)Estradiol-17βasanantioxidant:somedistinctfeatureswhencomparedwithcommonfat-solubleantioxidants.JLabClinMed.128:367–375..2.AzevedoRB,LacavaZG,MiyasakaCK,ChavesSB,CuriR.(2001)Regulationofantioxidantenzymeactivitiesinmaleandfemaleratmacrophagesbysexsteroids.BrazJMedBiolRes.34:683-687.3.BeckmanJS,KoppenolWH.(1996)Nitricoxide,superoxide,andperoxynitrite:thegood,thebad,andugly.AmJPhysiol.271:C1424–C1437.4.BeckV,RohrU,JungbauerA.(2005)phytoestrogensderivedfromredclover:Analternativetoestrogenreplacementtherapy?JSteroidBiochemMolBiol.94:499-518.5.Bednarek-TupikowskaG,TupikowskiK,BidziskaB,Bohdanowicz-PawlakA,Antonowicz-JuchniewiczJ,KosowskaB,MilewiczA.(2004)Serumlipidperoxidesandtotalantioxidantstatusinpostmenopausalwomenonhormonereplacementtherapy.GynecolEndocrinol.19:57–63.6.Bednarek-TupikowskaG,TworowskaU,JedrychowskaI,RadomskaB,TupikowskiK,Bidzinska-SpeichertB,MilewiczA.(2006)Effectsofoestradiolandoestroprogestinonerythrocyteantioxidativeenzymesystemactivityinpostmenopausalwomen.ClinEndocrinol(Oxf)64:463–468.7.BercoM,BhavnaniBR.(2001)Differentialneuroprotectiveeffectsofequuineestrogensagainstoxidizedlowdensitylipoprotein-inducedneuronalcelldeath.JSocGynecolInvestig.8:245–254.8.BonoA,CaimiG,CataniaA,SarnoA,PandolfoL.(1987)Redcellperoxidemetabolismindiabetesmellitus.HormMetabRes.19:264–266.9.BorrásC,GambiniJ,Gómez-CabreraMC,SastreJ,PallardóFV,MannGE,ViñaJ.(2005)17beta-oestradiolup-regulateslongevity-related,antioxidantenzymeexpressionviatheERK1andERK2[MAPK]/NFkappaBcascade.AgingCell.4:113–118.10.BorrasC,GambiniJ,VinaJ.(2007)Mitochondrialoxidantgenerationisinvolvedindeterminingwhyfemaleslivelongerthanmales.FrontBiosci.12:1008-1013.11.CadenasE,DaviesKJ.(2000)Mitochondrialfreeradicalgeneration,oxidativestress,andaging.FreeRadicBiolMed.Med.29:222–230.12.CapelID,JennerM,WilliamsDC,DonaldsonD,NathA.(1981)Theeffectofprolongedoralcontraceptivesteroiduseonerythrocyteglutathioneperoxidaseactivity.JSteroidBiochem.14:729-732.13.CavasL.(2005)Doesunderwaterrugbystimulatetheover-productionofreactiveoxygenspecies?CellBiochemFunct.23:59-63.14.Choi,DW.(1992)Excitotoxiccelldeath.J.Neurobiol.23:1261-1276.15.Díaz-FloresM,Baiza-GutmanLA,PedrónNN,HicksJJ.(1999)Uterineglutathionereductaseactivity:modulationbyestrogensandprogesterone.LifeSci.65:2481-2488.16.DucklesSP,KrauseDN.(2007)Cerebrovasculareffectsofoestrogen:multiplicityofaction.ClinExpPharmacolPhysiol.34:801-808.17.EdwardJ.Benz,SanfordJ.Shattil,BruceFurie,HarveyJ.Cohen,LeslieE.Silberstein,andPhilipMcGlave.(2005)Hoffman:Hematology:BasicPrinciplesandPractice,4thed:Hemoglobinfunction.18.Fernández-TresguerresHernándezJA.(2006)Molecularmechanismsofaginganditspreventionbyhormonaltreatmentinrats.AnRAcadNacMed(Madr).123:575-589.19.FinkelT,HolbrookNJ.(2000)Oxidants,oxidativestressandthebiologyofageing.Nature.408:239–247.20.FuXD,SimonciniT.(2007)Non-genomicsexsteroidactionsinthevascularsystem.SeminReprodMed.25:178-186.21.HaEJ,SmithAM.(2003)PlasmaSeleniumandPlasmaandErythrocyteGlutathionePeroxidaseActivityIncreasewithEstrogenduringtheMenstrualCycle.JAmCollNutr.22:43-51.22.HamdenK,SilandreD,DelalandeC,ElFekiA,CarreauS.(2008)Age-relateddecreaseinaromataseandestrogenreceptor(ERalphaandERbeta)expressioninrattestes:protectiveeffectoflowcaloricdiets.AsianJAndrol.10:177–187.23.HarmanD.(1956)Aging:atheorybasedonfreeradicalandradiationchemistry.JGerontol.11:298–300.24.HendersonVW,Paganini-HillA,MillerBL,ElbleRJ,ReyesPF,ShoupeD,McClearyCA,KleinRA,HakeAM,FarlowMR.(2000)EstrogenforAlzheimer''sdiseaseinwomen:randomized,double-blind,placebo-controlledtrial.Neurology.54:295–301.25.IwonaCicha,YojiSuzuki,NorihikoTateishiandNobujiMaeda.(1999)Rheologicalchangesinhumanredbloodcellsunderoxidativestress.Pathophysiology6:103-110.26.KankoferM,RadzkiRP,Bieko,AlberaE.(2007)Anti-oxidative/oxidativestatusofratliverafterovariectomy.JVetMedAPhysiolPatholClinMed.54:225-229.27.K.BagchiandS.Puri.(1998)Freeradicalsandantioxidantsinhealthanddisease.EastMediterrHealthJ.4:350-360.28.KimJ,KilIS,SeokYM,YangES,KimDK,LimDG,ParkJW,BonventreJV,ParkKM.(2006)Orchiectomyattenuatespost-ischemicoxidativestressandischemia/reperfusioninjuryinmice.Aroleformanganesesuperoxidedismutase.JBiolChem.281:20349-20356.29.KireevRA,TresguerresF,Vara,AriznavarretaC,TresguerresJA.(2007)EffectofchronictreatmentswithGH,melatonin,estrogens,andphytoestrogensonoxidativestressparametersinliverfromagedfemalerats.Biogerontology.8:469-482.30.KleinCB,KingAA..(2007)Genistein.genotoxicity:criticalconsiderationsofinvitroexposuredose.ToxicolApplPharmacol.224:1-11.31.LealM,DíazJ,SerranoE,AbellánJ,CarbonellLF.(2000)Hormonereplacementtherapyforoxidativestressinpostmenopausalwomenwithhotflushes.ObstetGynecol.95:804–809.32.LEEJong-Min;ANDERSONPeterC.;PADGITTJanetteK.;HANSONJaneanM.;WATERSChristopherM.;JOHNSONJeffreyA.(2003)Nrf2,nottheestrogenreceptor,mediatescatecholestrogen-inducedactivationoftheantioxidantresponsiveelement.BiochimBiophysActa.1629:92–101.33.LeungFP,TsangSY,WongCM,YungLM,ChanYC,LeungHS,YaoX,HuangY.(2007)tamoxifenandvasculartone.ClinExpPharmacolPhysiol.34:809-813.34.LeungSW,TeohH,KeungW,ManRY.(2007)Non-genomicvascularactionsoffemalesexhormones:physiologicalimplicationsandsignallingpathways.ClinExpPharmacolPhysiol.34:822-826.35.LiaoS,ChenW,KuoJ,ChenC.(2001)Associationofserumestrogenlevelandischemicneuroprotectioninfemalerats.NeurosciLett.297:159-162.36.LiochevSI,FridovichI(1999)TherelativeimportanceofHO•andONOO–inmediatingthetoxicityofO•-.FreeRadicBiolMed..26:777–778.37.L.M.Garcia-Segura,I.AzcoitiaandL.L.DonCarlos.(2001)Neuroprotectionbyestradiol.ProgNeurobiol.63:29–60.38.LutosawskaG,TkaczykJ,Panczenko-KresowskaB,Hübner-WoniakE,SkierskaE,GajewskiAK.(2003)PlasmaTBARS,bloodGSHconcentrations,anderythrocyteantioxidantenzymeactivitiesinregularlymenstruatingwomenwithovulatoryandanovulatorymenstrualcycles.ClinChimActa.331:159-163.39.MassafraC,BuonocoreG,BerniS,GioiaD,GiulianiA,VezzosiP.(1993)Antioxidanterythrocyteenzymeactivitiesduringoralcontraception.Contraception.47:591-596.40.MassafraC,BuonocoreG,GioiaD,SargentiniI.(1996)Changesintheerythrocyteantioxidantenzymesystemduringtransdermalestradioltherapyforsecondaryamenorrhea.GynecolEndocrinol.10:155–158.41.MassafraC,BuonocoreG,GioiaD,SargentiniI,FarinaG.(1997)Effectsofestradiolandmedroxyprogesterone-acetatetreatmentonerythrocyteantioxidantenzymeactivitiesandmalondialdehydeplasmalevelsinamenorrhoicwomen.JClinEndocrinolMetab.82:173-175.42.MassafraC,DeFeliceC,GioiaD,BuonocoreG.(1998)Variationsinerythrocyteantioxidantglutathioneperoxidaseactivityduringthemenstrualcycle.ClinEndocrinol(Oxf).49:63–67.43.Maziere,Auclair,M.,Ronveaux,FSalmon,S.,Santus,R.&Maziere,J.C.(1991)Estrogensinhibitcopperandcell-mediatedmodificationoflowdensitylipoprotein.AtherosclerSuppl.89:175–182.44.MillerAA,DeSilvaTM,JackmanKA,SobeyCG.(2007)Effectofgenderandsexhormonesonvascularoxidativestress.ClinExpPharmacolPhysiol.34:1037-1043.45.MiñanoA,CerbónMA,XifróX,MalageladaC,AguileraJ,Rodríguez-AlvarezJ.(2007)17beta-estradioldoesnotprotectcerebellargranulecellsfromexcitotoxicityorapoptosis.JNeurochem.102:354-364.46.MoreiraPI,NunomuraA,NakamuraM,TakedaA,ShenkJC,AlievG,SmithMA,PerryG.(2008)NucleicacidoxidationinAlzheimerdisease.FreeRadicBiolMed.44:1493–1505.47.MullerFL,LiuY,VanRemmenH.(2004)ComplexIIIreleasessuperoxidetobothsidesoftheinnermitochondrialmembrane.JBiolChem.279:49064–49073.48.MurphyE,SteenbergenC.(2007)Cardioprotectioninfemales:arolefornitricoxideandalteredgeneexpression.HeartFailRev.12:293-300.49.OzdenS,DildarK,KadirYH,GülizarK.(2001)Theeffectsofhormonereplacementtherapyonlipidperoxidationandantioxidantstatus.Maturitas.38:165-170.50.PintoRE,BartleyW.(1969)Thenatureofthesex-linkeddifferencesinglutathioneperoxidaseactivityandaerobicoxidationofglutathioneinmaleandfemaleratliver.BiochemJ.115:449-456.51.ProkaiL,SimpkinsJW.(2007)Structure-nongenomicneuroprotectionrelationshipofestrogensandestrogen-derivedcompounds.PharmacolTher.114:1-12.52.RadiR,CassinaA,HodaraR,QuijanoC,CastroL.(2002)Peroxynitritereactionsandformationinmitochondria.FreeRadicBiolMed.33:1451–1464.53.ReddyPH,BealMF.(2005)mitochondriacriticalinthepathogenesisofAlzheimer''sdisease?BrainResBrainResRev.49:618–632.54.RomeuM,MuleroM,GiraltM,FolchJ,NoguésMR,TorresA,FortuñoA,SuredaFX,CabréM,PaternáinJL,MallolJ.(2002)Parametersrelatedtooxygenfreeradicalsinerythrocytes,plasmaandepidermisofthehairlessrat.LifeSci.71:1739–1749.55.SackMN,RaderDJ,CannonRO3rd.(1994)Oestrogenandinhibitionofoxidationoflow-densitylipoproteinsinpostmenopausalwomen.Lancet.343:269–270.56.SatohM,MatterCM,OgitaH,TakeshitaK,WangCY,DornGW2nd,LiaoJK.(2007)Inhibitionofapoptosis-regulatedsignalingkinase-1andpreventionofcongestiveheartfailurebyestrogen.Circulation.115:3197-3204.57.SiowRC,LiFY,RowlandsDJ,deWinterP,MannGE.(2007)Cardiovasculartargetsforestrogensandphytoestrogens:transcriptionalregulationofnitricoxidesynthaseandantioxidantdefensegenes.FreeRadicBiolMed.42:909-925.58.SouthornPA,PowisG(1988)Chemicalnatureandbiologicreactions.MayoClinProc.63:381–389.59.SpectorA,MaW,WangRR,YangY,HoYS.(1997)TheContributionofGSHPeroxidase-1,CatalaseandGSHtotheDegradationofH2O2bytheMouse.Lens.ExpEyeRes.64:477-485.60.StarkovAA,FiskumG,ChinopoulosC,LorenzoBJ,BrowneSE,PatelMS,BealMF.(2004)Mitochondrialalpha-ketoglutaratedehydrogenasecomplexgeneratesreactiveoxygenspecies.J.Neurosci.24:7779–7788.61.StrassmannBI(1996)"Theevolutionofendometrialcyclesandmenstruation".QRevBiol.71:181–220.62.TsukamotoT,KatoR,KobayashiK(2007)HormonereplacementUp-to-date.Selectiveandrogenreceptormodulators(SARMs).Currentstatusandtheirfuture.ClinCalcium.17:1424-1428.63.TangM,AbplanalpW,AyresS,SubbiahMT.(1996)Superioranddistinctantioxidanteffectsofselectedestrogenmetabolitesonlipidperoxidation.Metabolism.45:411–414.64.TurrensJF(2003)Mitochondrialformationofreactiveoxygenspecies.J.Physiol.552:335–344.65.ValkoM,LeibfritzD,Moncol,CroninMT,MazurM,TelserJ.(2007)Freeradicalsandantioxidantsinnormalphysiologi-calfunctionsandhumandisease.IntJBiochemCellBiol.39:44–84.66.ViñaJ,SastreJ,PallardóFV,GambiniJ,BorrásC..(2006)Roleofmitochondrialoxidativestresstoexplainthedifferentlongevitybetweengenders:protectiveeffectofestrogens.FreeRadicRes.40:1359-1365.67.WallaceDC.(1999)Mitochondrialdiseasesinmanandmouse.Science.283:1482–1488.68.WebbP,LopezGN,UhtRM,KushnerPJ(1995)Tamoxifenactivationoftheestrogenreceptor/AP-1pathway:potentialoriginforthecell-specificestrogen-likeeffectsofantiestrogens.Mol.Endocrinol.9:443–456. 推文 網路書籤 推薦 評分 引用網址 轉寄                                                                                                                                                                                                                    top 相關論文 相關期刊 熱門點閱論文 無相關論文   1. 黃惠瑛、高美丁(1994)。

高雄地區孕婦之膳食攝食狀況。

中華民國營養學會雜誌，19，279-294 2. 詹秀妹(1989)，婦女懷孕時情緒、心理變化及行為反應，助產雜誌,31,16-18 3. 張素瓊(1991)。

台南地區孕乳婦營養素攝取之調查研究。

中華民國營養學會雜誌，16，101-118。

  1. 重金屬對於人類紅血球過氧化氫酶活性的影響 2. 維生素B-6對同半胱胺酸誘發小鼠氧化壓力後之半胱胺酸、穀胱甘肽及相關抗氧化酵素之影響 3. 穀胱甘肽代謝途徑之設計與分析 4. 維生素B2營養狀況對D-galactose誘發老化小鼠穀胱甘肽相關抗氧化系統之影響 5. 穀胱甘肽硫轉移酵素之基因多型性與肝細胞癌之相關性探討 6. 人工生殖懷雙胞胎孕婦體重增加型態與新生兒結果之相關 7. 選擇性半胱胺醯基白三烯素受體拮抗劑在老鼠氣喘模組上對基質金屬蛋白酵素表現調節之研究 8. 低眼壓之大白鼠視網膜細胞及視神經形態學的影響之觀察 9. 肺癌患者就診背景分析以中部某醫學中心為例 10. 血清乳酸去氫酶、C反應蛋白的濃度與急性生理和長期健康評估表II的計分和內科加護病房住院死亡的相關性研究 11. 四種半胱胺酸衍生物在MPTP處理之小鼠大腦中的抗氧化與抗發炎作用 12. 類黃酮分子結構與保護肝細胞活性關係之研究 13. 聚麩醯胺酸、聚丙胺酸、聚白胺酸對線蟲touchneurons功能影響的研究 14. 抗白點症病毒的胜肽疫苗之測試分析 15. 白色念珠菌CDC4結構域功能的解析     簡易查詢 | 進階查詢 | 熱門排行 | 我的研究室